# Peak cortisol response to corticotropin-releasing hormone is associated with age and body size in children referred for clinical testing: a retrospective review

**Authors:** Mary Ellen Vajravelu, Jared Tobolski, Evanette Burrows, Marianne Chilutti, Rui Xiao, Vaneeta Bamba, Steven Willi, Andrew Palladino, Jon M. Burnham, Shana E. McCormack

PMC · DOI: 10.1186/s13633-015-0018-y · International Journal of Pediatric Endocrinology · 2015-10-22

## TL;DR

This study found that in children undergoing CRH testing, larger body size and older age are linked to lower cortisol responses, suggesting potential issues with current dosing protocols.

## Contribution

The study identifies that body size and age independently affect cortisol response to CRH in children, suggesting a need for revised dosing or interpretation guidelines.

## Key findings

- Peak and delta cortisol responses to CRH are negatively associated with weight, height, BSA, and height z-score in children.
- Age is negatively associated with peak cortisol but not delta cortisol after CRH stimulation.
- Current weight-based dosing may not account for body size effects on cortisol response in pediatric patients.

## Abstract

Corticotropin-Releasing Hormone (CRH) testing is used to evaluate suspected adrenocorticotropic hormone (ACTH) deficiency, but the clinical characteristics that affect response in young children are incompletely understood. Our objective was to determine the effect of age and body size on cortisol response to CRH in children at risk for ACTH deficiency referred for clinical testing.

Retrospective, observational study of 297 children, ages 30 days – 18 years, undergoing initial, clinically indicated outpatient CRH stimulation testing at a tertiary referral center. All subjects received 1mcg/kg corticorelin per institutional protocol. Serial, timed ACTH and cortisol measurements were obtained. Patient demographic and clinical factors were abstracted from the medical record. Patients without full recorded anthropometric data, pubertal assessment, ACTH measurements, or clear indication for testing were excluded (number remaining = 222). Outcomes of interest were maximum cortisol after stimulation (peak) and cortisol rise from baseline (delta). Bivariable and multivariable linear regression analyses were used to assess the effects of age and size (weight, height, body mass index (BMI), body surface area (BSA), BMI z-score, and height z-score) on cortisol response while accounting for clinical covariates including sex, race/ethnicity, pubertal status, indication for testing, and time of testing.

Subjects were 27 % female, with mean age of 8.9 years (SD 4.5); 75 % were pre-pubertal. Mean peak cortisol was 609.2 nmol/L (SD 213.0); mean delta cortisol was 404.2 nmol/L (SD 200.2). In separate multivariable models, weight, height, BSA and height z-score each remained independently negatively associated (p < 0.05) with peak and delta cortisol, controlling for indication of testing, baseline cortisol, and peak or delta ACTH, respectively. Age was negatively associated with peak but not delta cortisol in multivariable analysis.

Despite the use of a weight-based dosing protocol, both peak and delta cortisol response to CRH are negatively associated with several measures of body size in children referred for clinical testing, raising the question of whether alternate CRH dosing strategies or age- or size-based thresholds for adequate cortisol response should be considered in pediatric patients, or, alternatively, whether this finding reflects practice patterns followed when referring children for clinical testing.

The online version of this article (doi:10.1186/s13633-015-0018-y) contains supplementary material, which is available to authorized users.

## Linked entities

- **Proteins:** POMC (proopiomelanocortin)
- **Chemicals:** corticorelin (PubChem CID 16186200)

## Full-text entities

- **Genes:** GH1 (growth hormone 1) [NCBI Gene 2688] {aka GH, GH-N, GHB5, GHN, IGHD1A, IGHD1B}, GGH (gamma-glutamyl hydrolase) [NCBI Gene 8836] {aka GATD10, GH}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, CRH (corticotropin releasing hormone) [NCBI Gene 1392] {aka CRF, CRH1}, POMC (proopiomelanocortin) [NCBI Gene 5443] {aka ACTH, CLIP, LPH, MSH, NPP, OBAIRH}
- **Diseases:** ACTH deficiency (MESH:C535668), seizures (MESH:D012640), hypoglycemia (MESH:D007003), decreased height (MESH:C000719188), Neoplasm (MESH:D009369), -pituitary abnormalities (MESH:D010900), adrenal suppression (MESH:D000310), primary adrenal insufficiency (MESH:D000224), obese (MESH:D009765), HPA (MESH:D010661), cortisol deficiency (MESH:C535280), short stature (MESH:D006130), overweight (MESH:D050177), multi-pituitary abnormalities (MESH:D015161), hypopituitarism (MESH:D007018), adrenal insufficiency (MESH:D000309), primary and (MESH:D010538), cardiovascular disease (MESH:D002318), GH deficiency (MESH:D004393)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4618529/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4618529/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC4618529/full.md

---
Source: https://tomesphere.com/paper/PMC4618529